TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

30.40$ +4.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Biodesix Inc (BDSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BDSX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
-18 -22 -21 -28 -45 -23 -49 -23
1.7 2.8 2.9 3.2 5.8 5.5 5.5 5.6
0.1 0.2 3.7 4.9 6.0 5.4 6.6 4.1
6.4 7.4 7.3 7.2 19 – – –
0.3 -1.6 -4.8 4.6 -4.3 11 -22 0.3
0.6 1.3 2.2 2.5 3.5 23 3.2 0.4
-0.6 -1.9 -2.9 -2.5 -3.5 -23 -3.4 -0.4
– – – 0.3 – 0.6 – –
– – – 0.3 0.4 0.6 0.6 0.5
11 13 16 -16 16 10.0 -0.1 10.0
19 23 81 1.3 59 29 52 16
0.7 -0.6 57 -30 10 -17 0.0 -7.3
-18 -23 -24 -31 -49 -46 -52 -24

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?